Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.26 - $1.53 $71,202 - $86,460
56,510 Added 223.31%
81,816 $115,000
Q1 2023

May 15, 2023

SELL
$1.2 - $1.53 $6,427 - $8,194
-5,356 Reduced 17.47%
25,306 $37,000
Q4 2022

Feb 14, 2023

BUY
$1.02 - $1.5 $31,275 - $45,993
30,662 New
30,662 $35,000
Q1 2022

May 16, 2022

SELL
$1.21 - $2.48 $654,397 - $1.34 Million
-540,824 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.84 - $2.68 $73,533 - $107,103
-39,964 Reduced 6.88%
540,824 $1.33 Million
Q3 2021

Nov 15, 2021

SELL
$2.26 - $2.86 $1.66 Million - $2.1 Million
-733,779 Reduced 55.82%
580,788 $1.46 Million
Q2 2021

Aug 16, 2021

BUY
$2.17 - $3.0 $130,278 - $180,108
60,036 Added 4.79%
1,314,567 $3.75 Million
Q1 2021

May 17, 2021

BUY
$1.77 - $3.1 $1.25 Million - $2.19 Million
707,316 Added 129.26%
1,254,531 $2.95 Million
Q4 2020

Feb 16, 2021

BUY
$0.95 - $1.83 $320,349 - $617,094
337,210 Added 160.57%
547,215 $963,000
Q3 2020

Nov 16, 2020

SELL
$0.75 - $1.09 $89,202 - $129,640
-118,936 Reduced 36.16%
210,005 $197,000
Q2 2020

Aug 14, 2020

BUY
$0.71 - $1.18 $118,078 - $196,243
166,308 Added 102.26%
328,941 $286,000
Q1 2020

May 15, 2020

SELL
$0.6 - $1.58 $114,643 - $301,893
-191,072 Reduced 54.02%
162,633 $135,000
Q4 2019

Feb 14, 2020

BUY
$0.54 - $1.01 $11,129 - $20,816
20,610 Added 6.19%
353,705 $315,000
Q3 2019

Nov 14, 2019

BUY
$0.85 - $1.24 $283,130 - $413,037
333,095 New
333,095 $326,000

Others Institutions Holding LCTX

About Lineage Cell Therapeutics, Inc.


  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $84.9M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.